Skip to main content
. 2021 Mar 19;1(2):e20. doi: 10.1002/ski2.20

TABLE 1.

Study information and patient population

First author Country Type of article Number of patients a How patients tested positive Age Gender
Hassan, K Scotland Case Report 1 RT‐PCR 46 F
Suter, P Switzerland Case Report 1 RT‐PCR 42 M
Shanshal, M Iraq Case Report 1 RT‐PCR 35 F
Lorenzo‐Villalba, N France Case Series 2 RT‐PCR 57 F
Freeman, E International Registry Case Series 23 (14) PCR, (5) antibody testing, and (4) unknown assay 41 median 11 F12 M
Lagziel, T USA Case Report 1 RT‐PCR 58 F
Eka Putraa, B Indonesia Case Report 1 RT‐PCR 29 M
Sakaida, T Japan Case Report 1 RT‐PCR 52 F
de‐Medeiros, V Brazil Case Report 1 RT‐PCR 55 F
Rivera‐Oyola, R USA Case Series 2 SARS‐CoV‐2 rapid respiratory panel 6060 MF
Gianotti R Italy Case Series 3 RT‐PCR 598989 FFM
Magro C USA Case Series 3 RT‐PCR 326640 MFF
Sachdeva M Italy Case Series 3 RT‐PCR 717772 F FF
Freeman, E International Registry Case Series 171 RT‐PCR 44 median 93 F78 M
Dalal, A India Observational Study 13 RT‐PCR 39.3 mean Unspecified
Elsaie, ML Saudi Arabia Case Report 1 RT‐PCR 57 M
Ho, B United Kingdom Case Report 1 RT‐PCR 79 F
Papamichalis, P Greece Case Report 1 RT‐PCR 68 M
Fernandez‐Nieto, L Spain Prospective Study 24 RT‐PCR 49.5 median 18 F6 M
Diaz‐Guimaraens, B Spain Case Report 1 RT‐PCR 48 M
a

Only includes patients reported in the study who were confirmed COVID‐19 positive and had dermatologic signs.